Julie Schneider to United States
This is a "connection" page, showing publications Julie Schneider has written about United States.
Connection Strength
0.810
-
Hospitalization, Alzheimer's Disease and Related Neuropathologies, and Cognitive Decline. Ann Neurol. 2019 12; 86(6):844-852.
Score: 0.112
-
Cognitive decline after elective and nonelective hospitalizations in older adults. Neurology. 2019 02 12; 92(7):e690-e699.
Score: 0.106
-
Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis. 2018; 64(s1):S161-S189.
Score: 0.099
-
GSK3? Interactions with Amyloid Genes: An Autopsy Verification and Extension. Neurotox Res. 2015 Oct; 28(3):232-8.
Score: 0.083
-
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology. 2004 Apr 13; 62(7):1148-55.
Score: 0.038
-
Off-label use of aducanumab for cerebral amyloid angiopathy. Lancet Neurol. 2021 08; 20(8):596-597.
Score: 0.032
-
Association of Lewy Bodies With Age-Related Clinical Characteristics in Black and White Decedents. Neurology. 2021 08 24; 97(8):e825-e835.
Score: 0.031
-
The "cognitive clock": A novel indicator of brain health. Alzheimers Dement. 2021 12; 17(12):1923-1937.
Score: 0.031
-
Person-Specific Contributions of Brain Pathologies to Progressive Parkinsonism in Older Adults. J Gerontol A Biol Sci Med Sci. 2021 03 31; 76(4):615-621.
Score: 0.031
-
Vascular dysfunction-The disregarded partner of Alzheimer's disease. Alzheimers Dement. 2019 01; 15(1):158-167.
Score: 0.026
-
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable. Alzheimers Dement. 2018 04; 14(4):563-575.
Score: 0.025
-
Urinary Incontinence, Incident Parkinsonism, and Parkinson's Disease Pathology in Older Adults. J Gerontol A Biol Sci Med Sci. 2017 Sep 01; 72(9):1295-1301.
Score: 0.024
-
Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease. Alzheimers Dement. 2016 Feb; 12(2):164-169.
Score: 0.021
-
Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol. 2015 Feb; 72(2):209-16.
Score: 0.020
-
Vascular contributions to cognitive impairment and dementia including Alzheimer's disease. Alzheimers Dement. 2015 Jun; 11(6):710-7.
Score: 0.020
-
Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of alzheimer dementia and detection of preclinical cortical amyloid. J Neuropathol Exp Neurol. 2014 Oct; 73(10):948-53.
Score: 0.020
-
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 2012 Jan; 8(1):1-13.
Score: 0.016
-
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 2012 Jan; 123(1):1-11.
Score: 0.016
-
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011 Sep; 42(9):2672-713.
Score: 0.016
-
Estimation of the mediation effect with a binary mediator. Stat Med. 2007 Aug 15; 26(18):3398-414.
Score: 0.012
-
Parkinsonian signs and functional disability in old age. Exp Aging Res. 2007 Jan-Mar; 33(1):59-76.
Score: 0.012
-
Parkinsonianlike signs and risk of incident Alzheimer disease in older persons. Arch Neurol. 2003 Apr; 60(4):539-44.
Score: 0.009
-
The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol. 2002 Jul; 59(7):1154-60.
Score: 0.008